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Abstract
ATM and PARP-1 are two of the most important players in the cell's response to DNA damage.
PARP-1 and ATM recognize and bound to both single and double strand DNA breaks in response
to different triggers. Here we report that ATM and PARP-1 form a molecular complex in vivo in
undamaged cells and this association increases after γ-irradiation. ATM is also modified by PARP-1
during DNA damage. We have also evaluated the impact of PARP-1 absence or inhibition on ATM-
kinase activity and have found that while PARP-1 deficient cells display a defective ATM-kinase
activity and reduced γ-H2AX foci formation in response to γ-irradiation, PARP inhibition on itself
is able to activate ATM-kinase. PARP inhibition induced γ H2AX foci accumulation, in an ATM-
dependent manner. Inhibition of PARP also induces DNA double strand breaks which were
dependent on the presence of ATM. As consequence ATM deficient cells display an increased
sensitivity to PARP inhibition. In summary our results show that while PARP-1 is needed in the
response of ATM to gamma irradiation, the inhibition of PARP induces DNA double strand breaks
(which are resolved in and ATM-dependent pathway) and activates ATM kinase.
Background
The ATM protein kinase is centrally involved in the cellu-
lar response to ionizing radiation (IR) and other DNA
double-strand-break-inducing insults. In persons affected
with ataxia-telangiectasia (A-T), associated mutations in
the ataxia-telangiectasia mutated (atm) gene render cells
unable to cope with the genotoxic stresses from ionizing
radiation and oxidative damage, thus resulting in a higher
concentration of unrepaired DNA. Functional inactiva-
tion of the ATM gene product and Atm-null mice, which
were created by disrupting the Atm locus, recapitulate the
human A-T phenotype and display growth retardation,
mild neurological dysfunction, male and female infertil-
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ity, extreme predisposition to thymic lymphomas, and
acute sensitivity to ionizing radiation [1-3].
ATM, the product of the ATM gene, is a member of a fam-
ily of large proteins found in various organisms that share
a COOH-terminal PI3 kinase-like domain. ATM has ser-
ine/threonine protein kinase activity and mediates the
activation of multiple signal transduction pathways
reviewed in [4-6].
Although it has been well established that IR exposure
activates the ATM kinase domain, the actual mechanism
by which ATM responds to damaged DNA has remained
enigmatic until recently. Initial evidences indicated that
ATM activation might involve autophosphorylation. A
breakthrough in our understanding of this process came
in a landmark publication by Bakkenist and Kastan [7].
They found that ATM molecules are inactive in undam-
aged cells, being held as dimers or higher-order multim-
ers. In this configuration, the kinase domain of each
molecule is blocked by the FAT domain of the other. Fol-
lowing DNA damage, each ATM molecule phosphorylates
the other on a serine residue at position 1981 within the
FAT domain, a phosphorylation that releases the two mol-
ecules from each other's grip, turning them into fully
active monomers.
Poly(ADP-ribose) polymerase (PARP-1) is a nuclear
enzyme which is activated in response to genotoxic insults
by binding damaged DNA and attaching polymers of
ADP-ribose to nuclear proteins at the expense of its sub-
strate NAD+. The protein respond to DNA damage by
transferring 50 to 200 molecules of ADP-ribose to various
nuclear proteins, including transcription factors, histones
and PARP-1 itself [8]. This poly(ADP-ribosyl)ation activ-
ity of PARP-1 appears to be important for maintaining
genomic integrity [9] and it has been associated with lon-
gevity. Furthermore, PARP-1 is activated by agents infring-
ing single stranded DNA damage such as alkylating
agents, ionizing radiation, and oxidative damage.
A function of PARP-1 as a nick sensor has been proposed
[10]. Its rapid activation upon DNA damage may result in
poly (ADP-ribosyl)ation of key enzymes such as transduc-
ers of DNA damage, or alternatively, PARP-1 automodifi-
cation could result in the recruitment of transducers to the
damaged site. In this regard, a link between ATM and
PARP-1 is supported by recent findings. One of these stud-
ies has demonstrated a sustained PARP-1 activation in
ATM-/- cells due to the persistence of DNA damage
[11,12]. Moreover, Menissier-de Murcia et al. [12], have
reported that ATM and PARP-1 double deficient mice
have a severe synergistic phenotypes leading to early
embryonic lethality due to the effects of these proteins on
signalling DNA damage and/or on distinct pathways of
DNA repair. Furthermore, a recent study has shown that
in vitro, PARP-1 inhibited the activation a subset of ATM
substrates such as phosphorylation of p53 on serine 15
[13].
The aim of this study has been to elucidate the interaction
between PARP-1 and ATM and how this partnership is
involved in regulation of DNA repair pathways. We
present evidences showing a physical association between
ATM and PARP-1 in response to DNA damage as well as a
poly (ADP-ribosyl)ation of ATM. The biological conse-
quence of this interaction is a diminished activation of
ATM-kinase in the absence of PARP-1. Surprisingly, pre-
venting poly(ADP-ribosyl)ation with PARP inhibitors
results in an increased constitutive ATM-kinase related to
the PARP inhibitor's ability to induce DNA double strand
breaks (DSBs) which were resolved in an ATM-dependent
manner.
Results
PARP-1 interacts with ATM in vivo and ATM is modified 
by poly(ADP-ribosyl)ation
Previous studies have shown that PARP-1 and ATM dou-
ble deficient mice are embryonic lethal very early during
development, suggesting that the two proteins together
are needed for the every day life of the animal [12]. In the
present study our principal aim was to test whether these
two proteins interact (both physical and functionally) in
the response to γ-radiation. Figure 1A shows an ATM co-
immunoprecipitation study using G361 cells (HT44, an
ATM deficient cell line, was used as a negative control).
ATM complexes were immunoprecipitated from nuclear
extracts using an antibody against ATM (SYR 10G3/1) and
the presence of PARP-1 was tested by immunoblot analy-
sis using an anti-PARP-1 antibody. ATM form a tight com-
plex with PARP-1 (1A, upper panels). Reciprocal
immunoprecipitation experiments confirmed the previ-
ous observation (not shown). Interestingly, this complex
was much more evident after DNA damage infringed with
either the single alkylating agent N-methyl-N-nitrosourea
(MNU, 2 mM) or 10 Gy of γ-irradiation. The interaction
was direct and not mediated by DNA since the presence of
ethidium bromide was not effective in abolishing the for-
mation of the complex and the specificity of the pull-
down was confirmed by the lack of co-immunoprecipita-
tion using an IgG control (not shown). These results were
confirmed by co-localisation studies with confocal micro-
scopy, where after γ-irradiation the number of co-local-
ised ATM/PARP-1 foci (yellow) increased respect to
untreated cells. Both ATM and PARP-1 are localised in foci
after DNA damage.
In order to check whether ATM was modified or not by
PARP-1 following DNA damage, the modification of ATM
by PARP-1 was analysed in a time course experiment usingBMC Molecular Biology 2007, 8:29 http://www.biomedcentral.com/1471-2199/8/29
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the same antibody to immunoprecipitate ATM (figure
2A). ATM is, indeed, modified by poly (ADP-rybosil)ation
and this modification increases during DNA damage,
reaching a maximum after 30 min and then start to
decrease. Polymer signal correspond to ATM molecular
weight. Again, confocal microscopy confirmed the co-
localisation of ATM and poly (ADP) ribose after ionizing
radiation (figure 2B). In conclusion, these results are the
first indication that ATM is physically associated to PARP-
1 and is a substrate for this enzyme, co-localizing in the
same foci after DNA damage.
PARP-1 is needed for optimal activation of ATM
One key question derived from the previous results con-
cern the functional consequences of the interaction
between PARP-1 and ATM and between poly (ADP-ribo-
syl)ation and ATM on ATM activation. To address this
question we have measured ATM kinase activity in wild
type and PARP-1 deficient cells and in the presence and
absence of the PARP inhibitor 4-amino,1–8,naphtalimide
(ANI). Splenocytes from parp-1+/+ and parp-1-/- mice or
G361 cells (a human melanoma cell line) were irradiated
at 10 Gy. ATM was immunoprecipitated 30 minutes after
the IR treatment and the ATM kinase assay performed (fig-
ure 2C). In these conditions ATM was strongly activated in
response to ionizing radiation in parp-1+/+ splenocytes
ATM form a complex with PARP-1 in DNA that is much more evident after treatment with DNA damaging agents Figure 1
ATM form a complex with PARP-1 in DNA that is much more evident after treatment with DNA damaging agents. A: ATM 
was immunoprecipitated in human melanoma cell lines G361 and HT144 (ATM deficient) as explained under methods and the 
presence of PARP-1 was tested by immunoblot analysis. Cells were treated with 10 Gy IR or 2 mM MNU for 30 min. In the left 
panel, PARP-1 was immunoprecipitated from G361 cells treated or not with 2 mM MNU and western blot was performed to 
reveal ATM. B: Double indirect immunofluorescence in 3T3 fibroblasts (parp-1+/+)of PARP-1 (red signal) and ATM (green). 
Yellow signal correspond with co-localization of both proteins.BMC Molecular Biology 2007, 8:29 http://www.biomedcentral.com/1471-2199/8/29
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but not in parp-1-/- (Figure 3A). In G361 and C3ABR cells
IR also activates ATM kinase but this increase was not
observed if prior to IR there was a pre-incubation with the
PARP inhibitor, ANI (figure 2C, middle and lower panel);
surprisingly, the simple presence of the PARP inhibitor
was able to activate ATM kinase.
PARP inhibitors promote ATM activation through 
induction of DSBs
To gain insight about the increased basal ATM-kinase
activity after the inhibition of PARP-1 with ANI (figure
2C), we performed an indirect inmunofluorescence
against H2AX in its phosphorylated form, after the incu-
bation with the PARP inhibitor in order to detect any
DNA damage response. ATM wild type and deficient cells
(G361 and HT144 respectively) were incubated with ANI
at different times. Remarkably the sole fact of the incuba-
tion with ANI was able to elicits H2AX phosphorylation in
wild type but not in ATM deficient cells. This effect was
transient and reached a peak in 2 hours, declining after-
wards (figure 3). γ-Irradiation was used as positive inter-
nal control (figure 3, upper panels). Previous results from
our group have shown that PARP-1 null cells have a defi-
cient p53 ser15 phosphorylation in response to ionising
radiation [15], confirming with a different ATM substrate
that ATM activation is compromised in the absence of
PARP-1.
Recent results have shown that inhibition of PARP leads
to stalled replication fork and the formation of DNA dou-
ble strand breaks that are resolved by homologous recom-
bination [17]. In order to test this possibility in our system
we performed neutral comet assay to detect double strand
breaks (DSB). DSB were produced by treatment with the
PARP inhibitor in both ATM proficient (G361) and defi-
cient (HT144) cells but only ATM wild type cells were able
to completely resolve double strand breaks (figure 4A).
PARP inhibition activates ATM through the induction of
DSBs which are repaired by HR; since ATM deficient cells
were less efficient in resolving DNA strand breaks that
ATM is modified by poly(ADP)ribose Figure 2
ATM is modified by poly(ADP)ribose. A: ATM was immunoprecipitated in G361 cells and the presence of poly(ADP ribose) 
was tested by immunoblot analysis in a time course, reaching a maximum after 15 min of IR (10 Gy). Equal loading was normal-
ized by the input of ATM. B: Double indirect immunofluorescence in 3T3 fibroblasts (parp-1+/+) of poly(ADP-ribose) (red sig-
nal) and ATM (green). Yellow signal correspond with poly(ADP-ribosyl)ation of ATM. C: PARP-1 is needed for optimal 
activation of ATM. In vitro ATM-kinase assay. ATM activity increases after γ-irradiation in wild-type mouse splenocytes, but 
not in parp-1 knockout mouse splenocytes, where ATM is activated in control (upper panels). In G361 cells and C3ABR (mid-
dle and lower panel) irradiated with or without ANI co-treatment, ATM kinase activity increases after γ-irradiation and/or 
PARP inhibitors. Equal loading was checked with coomasie blue staining. Normalized signal respect to coomassie blue is shown 
below. Results are representative of three independent experiments.BMC Molecular Biology 2007, 8:29 http://www.biomedcentral.com/1471-2199/8/29
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result from PARP inhibition we next examined their sen-
sitivity to ANI in the presence and absence of IR. Results
in figure 4B clearly show that ATM deficient cells are much
more sensitive to PARP inhibition with or without further
DNA damage.
Discussion
Cells have evolved various sophisticated pathways to
sense and overcome DNA damage as a mechanism to pre-
serve the integrity of the genome. Environmental attacks
like radiations or toxins, or spontaneous DNA lesions,
trigger checkpoint activation and consequent cell cycle
arrest leading to DNA repair or apoptosis. Two key pro-
teins that coordinate recognition of DNA damage and sig-
nal transduction to p53 are ATM and PARP-1. ATM and
PARP-1 participate in distinct forms of DNA repair that
partially compensate for each other. PARP-1 and ATM par-
ticipate in base excision repair (BER) and homologous
recombination (HR), respectively. It is normally assumed
that ATM signals for double strand breaks while PARP-1
participates in signalling from single DNA strand lesions.
Here we report that these two proteins form a molecular
complex that co-localizes in DNA damage foci.
Considerable evidence from in vitro, cell culture and ex
vivo  studies shows that poly(ADP-ribosyl)ation plays a
critical role in the survival and maintenance of genomic
stability of proliferating cells exposed to low or moderate
levels of DNA-damaging agents [18]. The data presented
in this study strongly support a role for PARP-1 and poly
(ADP-ribose) in ATM activation: in the absence of PARP-
1 there is a deficient ATM-kinase activation in response to
ionizing radiation as measured by intrinsic kinase activity
and H2AX phosphorylation. These results are in agree-
ment with previous data showing that PARP-1 deficient
mice are extremely sensitive to low doses of γ-radiation (as
is the case for ATM-null mice), and this phenotype could
be adscribed to a deficient ATM-kinase activation in tis-
sues such as the intestine epithelium [9]. Also, results
from our group have shown that p53 accumulation and
p53-dependent gene activation are compromised in parp-
1 knockout cells after γ-irradiation [15]. The insight of the
consequences of the poly(ADP-ribosyl)ation of ATM are
not clear yet since the inhibition of PARP induced indi-
rectly DNA DSB, initiating new responses to DNA damage
that interfere with elucidation of the activation of ATM.
PARP inhibitors have been used as radio and chemo-sen-
sitizers in a number of experimental settings and a mech-
anism for DSB induction through the collision of
unrepaired single DNA strand lesions with replication
forks has been suggested [19,20]. Early reports claimed
that the PARP inhibitor 3-aminobenzamide was a radio-
sensitizer only in rodent cells [21] however more recently
ANI (1000-fold more potent at inhibiting PARP activity
compared with 3-aminobenzamide (3-ABA)) has been
found to be radiation sensitizer to both rodent and
human tumor cells [9,15,22]. The novel PARP inhibitor
AG14361 has shown to increase the specificity and in vivo
activity to enhance radiation therapy of human cancer
through vasoactive effects and not directly in the cells in
culture [23]. Therefore the question still remains open as
to how human tumors could benefit from PARP inhibi-
tion during radiotherapy.
The second main conclusion in this study is that inhibi-
tion of PARP-1 activity leads to DSBs induction and acti-
vation of ATM and, at the same time, prevents IR-induced
ATM-kinase activity. From the results presented here,
there is a clear duality in the effect of PARP inhibition on
ATM: while the lack of response to IR in ANI treated cells
indicates that poly (ADP-rybosylation) of ATM is proba-
bly needed for optimal ATM activation, long term expo-
sure to PARP inhibitor results in the generation of DSBs
and secondarily in the activation of ATM kinase. DSBs
generated in this way are due to stalled replication fork
[24] and they are resolved by homologous recombination
(HR), providing a therapeutic opportunity to specifically
ATM is activated by PARP inhibitors Figure 3
ATM is activated by PARP inhibitors. Immunostaining for γ-
H2AX in G361 (ATM wild type) and HT144 (ATM deficient) 
cells exposed to γ-irradiation (positive control) or ANI (time 
course after drug exposure). H2AX (green signal) is phopho-
rilated by ATM after ANI treatment in absence of γ-irradia-
tion in G361 cells (ATM-proficient). DAPI is shown in blue 
and both views are in coincidence.BMC Molecular Biology 2007, 8:29 http://www.biomedcentral.com/1471-2199/8/29
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kill HR deficient tumor cells, as has been previously
shown by different laboratories [25,26].
In summary, our study demonstrates a strong association
between ATM and PARP-1 during the response to ionizing
radiation, being PARP-1 and its activity needed for opti-
mal activation of ATM kinase. On the other hand, inhibi-
tion of PARP leads to the activation of ATM kinase as
result of the generation of DSBs, making ATM deficient
cells particularly sensitive to PARP inhibitors.
Conclusion
In this study we demonstrate the physical interaction
between PARP-1 and ATM in response to ionizing radia-
tion, the modification of ATM by poly(ADP-ribose) and
the functional consequences of this interaction in PARP-1
deficient cells, where the activation of ATM kinase is com-
promised in response to IR. Additionally, PARP inhibition
induces DNA double strand breaks who are resolved in an
ATM-dependent manner. As result of that, ATM kinase is
activated by PARP inhibition and ATM deficient cells are
PARP inhibitors activate DSB repair by homologous recombination Figure 4
PARP inhibitors activate DSB repair by homologous recombination. A: neutral comet assay for detection of double strand 
breaks. For scoring the comet pattern, 800 nuclei from each slide were counted. HT144 ATM-deficient cells display more 
DSBs than G361 ATM-proficient cells after ANI treatment and only ATM wild type cells were able to completely resolve DSBs. 
Experiment is one representative of three similars. B: Analysis of cell death. Sub-G1 analysis was performed by flow cytometry 
using the propidium iodide (PI) DNA-staining method. Increased cell death with ANI is observed after long times of exposure 
(72 hours) in ATM-deficient cells (HT144, grey bars and ATM-proficient cells, G361, white bars) treated either with ANI alone 
or in combination with γ-irradiation respect ATM-proficient cells. Results represent the average ± SEM of three independent 
observations. * p < 0,05; **p < 0,01 respect to untreated HT144.BMC Molecular Biology 2007, 8:29 http://www.biomedcentral.com/1471-2199/8/29
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much more sensitive to PARP inhibition than ATM profi-
cient cells.
Methods
Cell culture and treatments
We have used immortalised (3T3) murine embryonic
fibroblasts expressing or lacking PARP-1 from parp-1 +/+
and -/- mice. G361 and HT144 are respectively wild type
and A-T cell lines from a melanoma patient [14] (a kind
gift from Dr. Y. Shiloh, Sackler School of Medicine, Tel
Aviv).
Cells were in exponential growth at the time of IR treat-
ment and the PARP inhibitor ANI was dissolved in culture
medium at a concentration of 10 µM. It was added 60 min
prior to IR. Irradiations, with or without ANI co-treat-
ment, were performed using a 60Co source at a dose rate
of 1.67 Gy/min. The used in all experiments was 10 Gy,
unless otherwise stated.
Indirect immunofluorescence
Immunostaining forATM, γ-H2AX, PARP-1 and PAR
(poly(ADP-ribose)) were performed on cells plated onto
coverslips and grown for 24 h before treatments. The
medium was removed, the coverslips rinsed twice in PBS
(37°C) and fixed in ice-cold methanol-acetone (1:1) for
10 minutes in the experiments with ATM, γ-H2AX, and in
formaldehyde 4% for 10 minutes in the experiments with
PARP-1 or PAR. The coverslips were rinsed twice in PBS-T
(PBS containing 0,1% Tween-20) prior to incubation with
primary antibody for 16 h at 4°C. The primary antibodies
used in these experiments were: rabbit polyclonal IgG
anti-phospho-H2AX (Ser139) (Upstate, Lake Placid, NY),
mouse monoclonal IgG anti-PARP (Ab-2, Oncogene).
anti-ATM mouse monoclonal antibody SYR 10G3/1 was a
kind gift from Y. Shiloh (Tel Aviv University); anti-PAR
rabbit polyclonal antibody was purchased from Biomol,
Plymouth Meeting, PA. The coverslips were rinsed 3 times
in PBS-T followed by a 45 min incubation at room tem-
perature in the dark and then rinsed 4 × 5 min in PBS-T.
The secondary antibodies used in this study were FITC-
conjugated goat anti-rabbit IgG (Sigma, St. Louis, MO)
and Cy3-conjugated sheep anti-mouse IgG (Sigma, St.
Louis, MO) at a concentration of 1:400. Antibodies were
diluted in PBS containing 1% bovine serum albumin and
5% goat serum. Nuclear counterstaining with 4',6'-dia-
midino-2-phenylindole dihydrochloride (DAPI) was per-
formed after removal of excess secondary antibody. Slides
were prepared using the Vectashield mounting medium
(Vector Lab., Inc., Burlingame, CA 94010), coverslipped
and stored in the dark at 4°C. Immunofluorescence
images were obtained linear range of detection to avoid
signal saturation using a Leica confocal microscopy.
Immunoprecipitation and western blotting assay
Cell extracts, SDS-PAGE electrophoresis and western blot-
ting were performed as previously described [15]. For
immunoprecipitation, cell lysates were precleared by con-
stant mixing for 2 hours with protein A-Sepharose (Phar-
macia). The beads were removed by centrifugation, and
the supernatant was mixed constantly overnight with a
monoclonal antibody against ATM (SYR 10G3/1) or
PARP-1 (Anti-PARP-1 Ab-2, Oncogene). Immune com-
plex were adsorbed onto protein A-Sepharose, boiled and
electrophoresed on polyacrylamide gels. The membranes
were probed with antibodies directed against ATM (SYR
10G3/1, Tel Aviv University), PARP-1 (Anti-PARP-1 Ab-2,
Oncogene) and Poli (ADP-Ribose) (Biomol).
In Vitro ATM-kinase assay
ATM kinase assays were conducted using the protocol
described by Sarkaria et al. [16]. ATM was immunoprecip-
itated from G361 cell extracts and from parp-1 +/+ and
parp-1 -/- murine spleen extracts. Briefly cell extracts were
prepared by resuspending cells in lysis buffer (20 mM
HEPES pH = 7.4, 150 mM NaCl, 1.5 mM MgCl2, 1 mM
EGTA, with protease inhibitors and 0.2% Tween during
20 minutes at 4°C. The lysates were clarified by centrifu-
gation and immunoprecipitations were carried out with
SYR 10G3/1 anti-ATM mouse monoclonal antibody.
Then immune complex were adsorbed onto protein A-
Sepharose and washed twice with kinase buffer (10 mM
HEPES pH = 7.4, 50 mM NaCl, 10 mM MgCl2) and once
with a high salt buffer (0.1 M Tris-HCl pH = 7.4, 0.6 M
NaCl). Kinase reactions were initiated with the addition
of an equal volume of kinase buffer containing PHAS-I
(20 ng/ml), 10 mM MnCl2, 1 mM DTT and 10 mM
[32P]ATP. Kinase reactions were performed at 30°C dur-
ing 20 minutes and terminated by the addition of 6×SDS
loading buffer (1:1), and reaction products were resolved
by SDS-PAGE. Incorporation of 32P into the PHAS-I sub-
strate was evaluated by phosphorimaging. All kinase reac-
tions were performed under linear reaction conditions.
Equal loading in each lane was guaranteed by coomasie
blue staining.
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